Skip to content

Human Factors and Home Use Study of the Vigilant Diabetes Management Application

Human Factors and Home Use Study of the Vigilant Diabetes Management Application

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02276131
Enrollment
61
Registered
2014-10-28
Start date
2015-01-31
Completion date
2015-12-31
Last updated
2016-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

A human factors and home use study to assess whether subjects with diabetes and their caregivers can understand feedback received from the Vigilant Diabetes Management Application about their blood glucose patterns and whether the decisions made in response to device feedback are made in accordance with the intended use.

Interventions

Human factors and usability assessment of the device in the hands of diabetes subjects and caregivers

Sponsors

University of Virginia
CollaboratorOTHER
InSpark Technologies, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Persons with diabetes mellitus testing blood glucose 3 or more times per day * Clinicians who see diabetes patients

Exclusion criteria

* Admission for diabetic ketoacidosis in the 6 months prior to enrollment * A recent injury to body or limb, muscular disorder, use of any medication, any carcinogenic disease, or other significant medical disorder if that injury, medication or disease in the judgment of the investigator will affect the completion of the protocol * Patients who are not willing to share their glucose meter data, or do not perform the tasks asked of them and follow instructions for the study will be excluded * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Adequate understanding of algorithmic feedback based on surveyed responses (Measure: units on a scale)1 month home useAn exit questionnaire will survey participants about comprehension of algorithmic feedback. Across all 5-point rating scales, the average rating will be determined.
Successful completion of frequent and risk-related tasks (Measure: Percent of tasks successfully completed)Controlled in-office testing for up to 2 hoursPercent successful initial or reattempt task completion across the range of usability tasks. Example: One task is to access the Trends screen to review and interpret weekly and monthly trend data for blood glucose variability and average glucose values.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026